PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Fast Ireland delivery — dispatched to Dublin, Cork, Galway, Limerick and nationwide.
PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Fast Ireland delivery — dispatched to Dublin, Cork, Galway, Limerick and nationwide.
By the Peptides Lab Ireland research team · Updated October 2026
BPC-157 in Ireland: this is our main research guide to the peptide. It covers what BPC-157 is, what lab and animal studies have looked at, what the evidence does not show, and how to check quality when sourcing it in Ireland. It brings together our earlier articles on BPC-157’s research benefits, tissue repair, gut research and timing in models, rewritten into one plain-English overview.
BPC-157 is not a licensed medicine in Ireland or the EU. It is supplied for laboratory research use only and is not for human or veterinary use.
BPC-157 stands for Body Protection Compound-157. It is a peptide, which is a short chain of amino acids, in this case 15 of them. Its sequence is a fragment of a protein found in human gastric juice. Most of the early research came from a group at the University of Zagreb led by Professor Predrag Sikiric, and labs in other countries have since joined in.
One unusual thing about BPC-157 is that it is fairly stable in gastric juice, where most peptides break down quickly. That stability is one reason it has been studied so much in gut models.
Below are the main areas covered in the published literature. They describe findings in cell cultures and animal models. They are not proven outcomes in people.
This is the most cited area. In a 2011 study, BPC-157 increased the outgrowth, survival and migration of rat tendon cells in the lab, and helped tendon healing in rats. Chang et al., J Appl Physiol 2011 (PMID 21030672). A 2019 review collected the animal studies on muscle, tendon, ligament and bone and concluded that, while the results are consistent, human trials are still lacking. Gwyer et al., Cell Tissue Res 2019 (PMID 30915550).
Given where its sequence comes from, BPC-157 has been studied a lot in gut models. Rodent studies have looked at lesions caused by alcohol, aspirin-type drugs (NSAIDs) and stress, and at models of inflammatory bowel conditions. Researchers have also explored links between the gut and the brain, known as the brain-gut axis. Sikiric et al., Curr Neuropharmacol 2016 (PMID 27138887).
Many repair processes depend on new blood vessels forming. A 2017 study found that BPC-157 increased the expression and activation of VEGFR2, a key receptor for blood-vessel growth, in cells and in a rat model. Hsieh et al., J Mol Med 2017 (PMID 27847966). This is often suggested as one of the ways it may act in repair models.
The exact mechanism is still not settled. Studies point to several signalling routes rather than one receptor: the VEGF pathway (blood vessels), the nitric oxide system (blood flow), FAK-paxillin signalling (cell movement), and growth-factor signalling linked to collagen and connective tissue. Some rodent studies also report effects on serotonin and dopamine systems, but this work is at an early stage.
People often ask how quickly BPC-157 “works”. In research terms, that depends entirely on the model. Published animal studies measure outcomes at different points, from the first days after an induced injury up to several weeks, using tissue samples (histology), strength testing and molecular markers. There is no single timeline, and animal timelines cannot be applied to people. For study-specific methods, always go to the primary papers.
Being straight about this matters. There is very little controlled human trial data on BPC-157. Effect sizes, long-term safety and reproducibility outside the original research groups are still open questions. Anyone describing “benefits” should frame them as preclinical findings, not established results in people. For a balanced view, read our summary of what the research shows on BPC-157 side effects and safety.
BPC-157 is often studied alongside TB-500, a synthetic fragment of the protein thymosin beta-4. They appear to work through different routes: BPC-157 through growth-factor and nitric-oxide signalling, TB-500 through actin binding and cell migration. See our BPC-157 vs TB-500 comparison and the TB-500 Ireland guide. We also supply a ready-made BPC-157 + TB-500 research blend.
When sourcing BPC-157 in Ireland, purity is the single most important factor. If the compound is not what the label says, results cannot be repeated. Research labs generally expect at least 98% purity by HPLC. Every batch of BPC-157 from Peptides Lab Ireland comes with:
Orders are dispatched from within Ireland with tracked delivery, so there are no customs delays.
Lyophilised BPC-157 is best kept at -20°C for long-term storage, away from light and moisture. Short-term storage at 2-8°C is fine for a short research window. Once dissolved (for example in bacteriostatic water), keep the solution refrigerated and split it into single-use portions to avoid repeated freeze-thaw cycles, which break the peptide down. Our peptide storage guide has more detail, and the peptide concentration calculator works out solution strength for lab prep.
BPC-157 is not a controlled substance under Irish or EU law, and it is not an authorised medicine. It can be bought and held for laboratory research, but it cannot legally be sold for human use or treatment. The Health Products Regulatory Authority (HPRA) regulates anything presented as a medicine. Read more in Is BPC-157 legal in Ireland? and our HPRA guide.
BPC-157 (Body Protection Compound-157) is a synthetic peptide made of 15 amino acids. Its sequence comes from a protein found in human gastric juice. It is a research compound, not an authorised medicine.
BPC-157 is not a controlled substance in Ireland and is not an authorised medicine. It can be supplied for laboratory research use only, without health claims. It cannot legally be sold for human use. See our full guide: Is BPC-157 legal in Ireland?
Mostly tissue-repair models in the lab: tendon and muscle, the gut lining, and blood-vessel growth (angiogenesis). Almost all of this work is in cell cultures and animals, so it does not show effects in people.
Very little. Controlled human trial data is limited, so any reported effects should be read as preclinical findings only.
Research-grade BPC-157 should show at least 98% purity on HPLC, with mass spectrometry confirming its identity. Every Peptides Lab Ireland batch comes with a Certificate of Analysis.
Standard delivery to Irish addresses is 1 to 3 working days from dispatch, tracked on every order.
Ready to source BPC-157 in Ireland? Every vial is HPLC-verified and ships with a batch Certificate of Analysis. You can also browse the full research peptides Ireland range or the shop. Questions: research@peptideslabireland.com.
BPC-157 is supplied by Peptides Lab Ireland for laboratory research use only. It is not a licensed medicine and has not been approved for human or veterinary use by the HPRA or any EU regulator. It must not be given to humans or animals. For medical concerns, speak to a qualified healthcare professional.
Receive News
